Search

Your search keyword '"Licht, Christoph"' showing total 1,301 results

Search Constraints

Start Over You searched for: Author "Licht, Christoph" Remove constraint Author: "Licht, Christoph"
1,301 results on '"Licht, Christoph"'

Search Results

6. DEVELOPING THERAPIES FOR C3G: REPORT OF THE KIDNEY HEALTH INITIATIVE C3G TRIAL ENDPOINTS WORK GROUP

7. The role of complement in kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

8. Utilizing therapeutic drug monitoring to optimize therapy with eculizumab and mycophenolate mofetil in a child with C3 glomerulonephritis

10. C3 Glomerulopathies

13. Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activation

17. Nutritional and Anthropometric Indices in Children Receiving Haemodiafiltration vs Conventional Haemodialysis - The HDF, Heart and Height (3H) Study

18. The Role of Complement in Kidney Disease: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

22. Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation

23. Complement-Mediated Two-Step NETosis: Serum-Induced Complement Activation and Calcium Influx Generate NADPH Oxidase-Dependent NETs in Serum-Free Conditions.

25. Characterization of patients with aHUS and associated triggers or clinical conditions: A Global aHUS Registry analysis

26. WCN24-636 PROLONGED REMISSION AFTER CYCLOPHOSPHAMIDE AND TACROLIMUS TREATMENT IN CHILDHOOD NEPHROTIC SYNDROME: A PROSPECTIVE COHORT STUDY

28. Hemodiafiltration Is Associated With Reduced Inflammation and Increased Bone Formation Compared With Conventional Hemodialysis in Children: The HDF, Hearts and Heights (3H) Study

31. An expert discussion on the atypical hemolytic uremic syndrome nomenclature—identifying a road map to precision: a report of a National Kidney Foundation Working Group

32. Hemodiafiltration maintains a sustained improvement in blood pressure compared to conventional hemodialysis in children—the HDF, heart and height (3H) study

33. Long-Term Outcomes of C3 Glomerulopathy and Immune-Complex Membranoproliferative Glomerulonephritis in Children

34. Impact of steroids and steroid-sparing agents on quality of life in children with nephrotic syndrome

38. Technical requirements and devices available for long-term hemodialysis in children—mind the gap!

40. Adressen

49. Glomeruläre Erkrankungen

Catalog

Books, media, physical & digital resources